Long-Term Clinical Outcomes With Sirolimus-Eluting Coronary Stents

Morice, 2002, Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions, N Engl J Med, 346, 1773, 10.1056/NEJMoa012843 Moses, 2003, Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, N Engl J Med, 349, 1315, 10.1056/NEJMoa035071 Schofer, 2003, Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS), Lancet, 362, 1093, 10.1016/S0140-6736(03)14462-5 Schampaert, 2004, The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS), J Am Coll Cardiol, 43, 1110, 10.1016/j.jacc.2004.01.024 Fajadet, 2005, Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents, Circulation, 111, 1040, 10.1161/01.CIR.0000156334.24955.B2 Serruys, 2002, Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial, Circulation, 106, 798, 10.1161/01.CIR.0000025585.63486.59 Cutlip, 2007, Clinical endpoints in coronary stent trials—a case for standardized definitions, Circulation, 115, 2344, 10.1161/CIRCULATIONAHA.106.685313 Carter, 2004, Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model, Cardiovasc Res, 63, 617, 10.1016/j.cardiores.2004.04.029 Sousa, 2001, Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study, Circulation, 103, 192, 10.1161/01.CIR.103.2.192 Colombo, 2003, Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions, Circulation, 108, 788, 10.1161/01.CIR.0000086926.62288.A6 Stone, 2004, One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial, Circulation, 109, 1942, 10.1161/01.CIR.0000127110.49192.72 Fajadet, 2006, Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial, Circulation, 114, 798, 10.1161/CIRCULATIONAHA.105.591206 Beijk, 2007, XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent, Expert Rev Med Devices, 4, 11, 10.1586/17434440.4.1.11